• Nuwellis appointed Dale Brady as principal R&D engineer to support existing and new product development programs.
• Brady previously held executive leadership roles at Peytant Solutions and Endogenex, directing engineering and operations for commercialization and clinical development.
• He also spent nearly a decade at Osprey Medical leading next-generation cardiovascular technology development.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nuwellis Inc. published the original content used to generate this news brief on August 06, 2026, and is solely responsible for the information contained therein.